Keyphrases
Antifibrotic
100%
Pancreatic Ductal Adenocarcinoma
100%
Immune Landscape
100%
Stromal Barriers
100%
Effective Compounds
50%
Halofuginone
50%
Drug Delivery
33%
Physical Barrier
33%
Tumor
16%
Extracellular Matrix
16%
Anti-tumor Immune
16%
Tumor Immunity
16%
Immune Cells
16%
Stroma-targeting Therapy
16%
Carcinoma Cells
16%
Immune Therapy
16%
Autochthonous
16%
Engineering Approach
16%
Matrix Elements
16%
Physiological Condition
16%
Current Therapies
16%
Cytotoxic T Cells
16%
Tumor Volume
16%
Drug Distribution
16%
Genetically Engineered Mouse Models
16%
Fibroblast Activation
16%
Tumor Survival
16%
Stromal Microenvironment
16%
Stromal Resistance
16%
Immune Infiltrates
16%
Inflammatory Macrophages
16%
Tumor Protection
16%
Intratumoral Necrosis
16%
Classically Activated
16%
Biochemistry, Genetics and Molecular Biology
Mouse Model
100%
Macrophage
100%
Immunocompetent Cell
100%
Tumor Volume
100%
Genetically Engineered Mouse Strain
100%
Drug Distribution
100%
Cytotoxic T Cell
100%
Fibroblast
100%
Immunology and Microbiology
Immune Landscape
100%
Stroma
100%
Macrophage
25%
Immunosuppressive Drug
25%
Cytotoxic T Cell
25%
Carcinoma Cell
25%
Mouse Model
25%
Immunocompetent Cell
25%
Tumor Volume
25%
Genetically Engineered Mouse Strain
25%
Drug Distribution
25%
Extracellular Matrix
25%
Immunotherapy
25%
Fibroblast
25%
Medicine and Dentistry
Pancreas Adenocarcinoma
100%
Stroma
66%
Neoplasm
50%
Halofuginone
50%
Malignant Neoplasm
16%
Cytotoxic T-Cell
16%
Carcinoma Cell
16%
Extracellular Matrix
16%
Immunocompetent Cell
16%
Necrosis
16%
Macrophage
16%
Drug Distribution
16%
Antifibrotic Agent
16%
Immunosuppressive Drug
16%
Immunotherapy
16%
Fibroblast
16%
Pharmacology, Toxicology and Pharmaceutical Science
Pancreas Adenocarcinoma
100%
Neoplasm
50%
Halofuginone
50%
Mouse Model
16%
Drug Distribution
16%
Genetically Engineered Mouse Strain
16%
Malignant Neoplasm
16%
Immunosuppressive Agent
16%
Necrosis
16%
Antifibrotic Agent
16%
Immunotherapy
16%
Carcinoma
16%
Neuroscience
Halofuginone
100%
Macrophage
33%
T Cell
33%
Extracellular Matrix
33%
Immunotherapy
33%
Immunosuppressive Drug
33%
Necrosis
33%
Fibroblast
33%